Harmony Biosciences Holdings, Inc. (HRMY) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

18/25

Growth 5 Margin 5 Expansion 3 Platform 1 Financial 4

latest quarter score

Earnings Reports

18
Harmony Biosciences (HRMY) Q2 2026: WCAG Net Revenue Jumps 30% as BP205 Data Sets Up Pipeline Catalysts
August 05, 2026
13
Harmony Biosciences (HRMY) Q1 2026: OpEx Jumps 38% as Business Development and Pipeline Investment Accelerate
May 07, 2026
17
Harmony Biosciences (HRMY) Q4 2025: WAKIX Revenue Surges 21% as Blockbuster Status Beckons
February 26, 2026
18
Harmony Biosciences (HRMY) Q4 2025: WAKIX Revenue Jumps 21% as Franchise Expands Toward Blockbuster Milestone
February 25, 2026
18
Harmony Biosciences (HRMY) Q3 2025: Patient Adds Rise by 500, Accelerating Blockbuster WAKIX Trajectory
November 04, 2025
19
Harmony Biosciences (HRMY) Q2 2025: WAKIX Growth Fuels 16% Revenue Rise Amid Pipeline Milestones
August 05, 2025
19
AG Mortgage Investment Trust (MITT) Q1 2025: Home Equity Portfolio Grows 78%, Signaling Early-Stage Asset Class Bet
July 06, 2025

Browse all companies